NEW YORK (Reuters Health) – The dopamine agonist pramipexole relieves depressive symptoms in patients with Parkinson’s disease, according to a study published online May 10th in The Lancet…
NEW YORK (Reuters Health) – Dizziness in the elderly is caused by cardiovascular disease in over half of patients seen in primary care, according to new research from…
NEW YORK (Reuters Health) – Patients with vascular dementia who took the acetylcholinesterase inhibitor donepezil had mild improvements in cognitive function, but not global function, in an international…
NEW YORK (Reuters Health) – The TNF alpha inhibitor adalimumab provides minor analgesia in patients with radicular pain due to lumbar disc herniation, but prompts a major reduction…
NEW YORK (Reuters Health) – Using recombinant tissue plasminogen activator (rtPA) within existing licensing limits is fully justified by available data – but there’s not enough data to…
NEW YORK (Reuters Health) – Intravenous magnesium sulfate (MgSO4) does not benefit patients with acute aneurysmal subarachnoid hemorrhage, according to results of a phase III trial. In the…
NEW YORK (Reuters Health) – A comparison of 10 seizure drugs in older epilepsy patients shows that lamotrigine is the most effective — based on 12-month retention and…
NEW YORK (Reuters Health) – Intra-arterial fibrinolysis improves outcomes after acute ischemic stroke, a meta-analysis confirms — and although the treatment increases the risk of hemorrhage, that doesn’t…
NEW YORK (Reuters Health) – Lithium did not delay the progression of amyotrophic lateral sclerosis (ALS) in a randomized placebo-controlled trial, the investigators reported online April 6 in…
NEW YORK (Reuters Health) – Adding pregabalin (Lyrica) to existing therapy for poorly controlled partial seizures reduces seizure frequency and is generally well tolerated over the long term,…